Dr Manjari Chandran-Ramesh

Dr Manjari Chandran-Ramesh is a Partner in Amadeus Capital Partners and her investment focus is on AI, Robotics and Quantum Technologies. In more than a decade in Venture, she has experience raising several £100m for her portfolio companies, exiting 3 companies and operational experience as acting CEO. She is the Amadeus representative on several boards including Ravelin (acquired by WorldPay), NuQuantum, Seldon, Photonic, Tenzo and Safe Intelligence.

A Rhodes Scholar and a Kauffman fellow, Manjari started her career in academia, after a PhD in Autonomous Vehicles, as a researcher and college lecturer at Oxford University, later moving to technology transfer at the University where she was responsible for commercialising intellectual property. Manjari then worked at IP Group plc, managing technology investments from deal origination to exit. She was responsible for the trade sale of TheySay Ltd (emotional AI acquired by Aptean), secondary share sale exit in Concirrus Ltd (AI in InsureTech), and sourcing and working with the founding team to build Quantum Motion Ltd (Quantum Computing in Silicon). Manjari created and led IP Group’s Quantum Technologies investment strategy, setting up an initial £12m accelerator fund in partnership with Innovate UK.

On a personal capacity, she is currently on the Strategic Advisory Board that advises the UK Government’s National Quantum Technologies Programme, the Royal Academy of Engineering’s Enterprise Hub Committee and the Satellite Applications Catapult.